Milena P. Mak

Department Of Thoracic/Head And Neck Medical Oncology
Sao Paulo, SP, Brazil

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 34 publications

Malignant salivary gland tumors in Brazil: epidemiology, treatment patterns, and survival outcomes in public Brazilian population.

Malignant salivary gland tumors in Brazil: epidemiology, treatment patterns, and survival outcomes in public Brazilian population.

Journal: Gland surgery

Published: November 26, 2025

Metastatic Colorectal Adenocarcinoma with APC and EGFR L858R co-mutations: A Case Report.

Metastatic Colorectal Adenocarcinoma with APC and EGFR L858R co-mutations: A Case Report.

Journal: The oncologist

Published: September 09, 2025

Metastatic colorectal adenocarcinoma with APC and EGFR L858R co-mutations: a case report.

Metastatic colorectal adenocarcinoma with APC and EGFR L858R co-mutations: a case report.

Journal: The oncologist

Published: September 09, 2025

Challenges and Opportunities in Head and Neck Cancer Research in Developing Countries: Insights From a Fireside Chat.

Challenges and Opportunities in Head and Neck Cancer Research in Developing Countries: Insights From a Fireside Chat.

Journal: JCO global oncology

Published: September 09, 2025

Anti-PD-1 antibody penpulimab plus chemotherapy for recurrent or metastatic nasopharyngeal carcinoma: a randomized, double-blind phase 3 study.

Anti-PD-1 antibody penpulimab plus chemotherapy for recurrent or metastatic nasopharyngeal carcinoma: a randomized, double-blind phase 3 study.

Journal: Signal transduction and targeted therapy

Published: August 12, 2025

Enhanced Versus Standard Dermatologic Management With Amivantamab-Lazertinib in EGFR-Mutated Advanced NSCLC: The COCOON Global Randomized Controlled Trial.

Enhanced Versus Standard Dermatologic Management With Amivantamab-Lazertinib in EGFR-Mutated Advanced NSCLC: The COCOON Global Randomized Controlled Trial.

Journal: Journal of thoracic oncology : official publication of the International Association for the Study of Lung Cancer

Published: June 17, 2025

Brief Report: Post Hoc Validation of Platinum Ineligibility in NSCLC From the Phase III IPSOS Study.

Brief Report: Post Hoc Validation of Platinum Ineligibility in NSCLC From the Phase III IPSOS Study.

Journal: Journal of thoracic oncology : official publication of the International Association for the Study of Lung Cancer

Published: March 31, 2025

Preoperative neoadjuvant chemotherapy or immunotherapy in head and neck cancer: A systematic review and meta-analysis of surgical risk and pathologic response.

Preoperative neoadjuvant chemotherapy or immunotherapy in head and neck cancer: A systematic review and meta-analysis of surgical risk and pathologic response.

Journal: Critical reviews in oncology/hematology

Published: March 14, 2025

The Phase 3 KEYLYNK-006 Study of Pembrolizumab Plus Olaparib Versus Pembrolizumab Plus Pemetrexed as Maintenance Therapy for Metastatic Nonsquamous NSCLC.

The Phase 3 KEYLYNK-006 Study of Pembrolizumab Plus Olaparib Versus Pembrolizumab Plus Pemetrexed as Maintenance Therapy for Metastatic Nonsquamous NSCLC.

Journal: Journal of thoracic oncology : official publication of the International Association for the Study of Lung Cancer

Published: August 22, 2024

Real-world data on the efficacy and toxicity of induction chemotherapy in locally advanced nasopharyngeal carcinoma in a non-endemic population.

Real-world data on the efficacy and toxicity of induction chemotherapy in locally advanced nasopharyngeal carcinoma in a non-endemic population.

Journal: Ecancermedicalscience

Published: July 20, 2024

Latin American Consensus on the Treatment of Head and Neck Cancer.

Latin American Consensus on the Treatment of Head and Neck Cancer.

Journal: JCO global oncology

Published: April 11, 2024

Prospective Cohort Study Identifies Medical Predictors of Treatment-Related Oral Toxicities in Oral and Oropharyngeal Cancer Patients.

Prospective Cohort Study Identifies Medical Predictors of Treatment-Related Oral Toxicities in Oral and Oropharyngeal Cancer Patients.

Journal: Dentistry journal

Published: November 28, 2023

Showing 1-12 of 34

Last Updated: 09/26/2026